Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years

NCT ID: NCT01764204

Last Updated: 2018-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30840 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2018-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To highlight the incidence of adverse reactions of Qingkailing Injection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adverse Drug Events Adverse Drug Reactions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Qingkailing Injection

Qingkailing Injection

Intervention Type DRUG

Qingkailing Injection is a kind of natural product injection made from Chinese herbs, which has been used to treat cerebral ischemia for decades in China. The main bioactive ingredients of this injection include Baicalin, Jasminoidin, Ursodeoxycholic Acid, Concha Margaritifera,etc.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qingkailing Injection

Qingkailing Injection is a kind of natural product injection made from Chinese herbs, which has been used to treat cerebral ischemia for decades in China. The main bioactive ingredients of this injection include Baicalin, Jasminoidin, Ursodeoxycholic Acid, Concha Margaritifera,etc.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Shineway Qingkailing Injection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all the patients treated by Qingkailing Injection in the certain centers(hospitals) in the next 2 years.
* in accordance with ethics requirements.

Exclusion Criteria

* none.
Minimum Eligible Age

1 Year

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

China Academy of Chinese Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhong Wang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhong Wang, Ph.D., M.D.

Role: PRINCIPAL_INVESTIGATOR

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Defense University Hospital of People's Liberation Army

Beijing, Beijing Municipality, China

Site Status

Ren'ai Hospital

Shenzhen, Guangdong, China

Site Status

Chinese Medicine Hospital of Deqing County

Zhaoqing, Guangdong, China

Site Status

Chinese Medicine Hospital of Gaoyang County

Baoding, Hebei, China

Site Status

Gaoyang County Hospital

Baoding, Hebei, China

Site Status

The Third People's Hospital of Xiong County

Baoding, Hebei, China

Site Status

Chinese Medicine Hospital of Xiong County

Baoding, Hebei, China

Site Status

Chinese Medicine Hospital of Tang County

Baoding, Hebei, China

Site Status

People's Hospital of Tang County

Baoding, Hebei, China

Site Status

Chinese Medicine Hospital of Handan City

Handan, Hebei, China

Site Status

The First Hospital of Yongnian District

Handan, Hebei, China

Site Status

The Second Hospital of Yongnian District

Handan, Hebei, China

Site Status

Central Hospital of Shijiazhuang City

Shijiazhuang, Hebei, China

Site Status

Hebei Chest Hospital

Shijiazhuang, Hebei, China

Site Status

Chinese Medicine Hospital of Shijiazhuang City

Shijiazhuang, Hebei, China

Site Status

Central Hospital of Qinghe County

Xingtai, Hebei, China

Site Status

Chinese Medicine Hospital of Xingtai City

Xingtai, Hebei, China

Site Status

Eye Hospital of Xingtai City

Xingtai, Hebei, China

Site Status

The Second Affiliated Hospital of Xingtai Medical College

Xingtai, Hebei, China

Site Status

Chinese Medicine Hospital of Qinghe County

Xingtai, Hebei, China

Site Status

The Second Hospital of Bayan County

Harbin, Heilongjiang, China

Site Status

Luohe Hospital of Chinese Medicine

Luohe, Henan, China

Site Status

Central Hospital of Sanmenxia City

Sanmenxia, Henan, China

Site Status

People's Hospital of Shan County

Sanmenxia, Henan, China

Site Status

The First People's Hospital of Lingbao

Sanmenxia, Henan, China

Site Status

Chinese Medicine Hospital of Xinxiang City

Xinxiang, Henan, China

Site Status

The Third Affiliated Hospital of Xinxiang Medical University

Xinxiang, Henan, China

Site Status

People's Hospital of Yanjin County

Xinxiang, Henan, China

Site Status

Chinese Medicine Hospital of Fengqiu County

Xinxiang, Henan, China

Site Status

People's Hospital of Fengqiu County

Xinxiang, Henan, China

Site Status

People's Hospital of Yuanyang County

Xinxiang, Henan, China

Site Status

People's Hospital of Xinzheng City

Xinzheng, Henan, China

Site Status

Third Affiliated Hospital of Henan College of Traditional Chinese Medicine

Zhengzhou, Henan, China

Site Status

Chinese Medicine Hospital of Xinzheng

Zhengzhou, Henan, China

Site Status

Affiliated Zhongshan Hospital of Dalian University

Dalian, Liaoning, China

Site Status

Central Hospital of Liaocheng City

Liaocheng, Shandong, China

Site Status

Veterans'Hospital

Liaocheng, Shandong, China

Site Status

Chinese Medicine Hospital of Dongchangfu District

Liaocheng, Shandong, China

Site Status

Chinese Medicine Hospital of Chiping County

Liaocheng, Shandong, China

Site Status

YangGuXian People's Hospital

Liaocheng, Shandong, China

Site Status

Chinese Medicine Hospital of Linqing

Liaocheng, Shandong, China

Site Status

Chinese Medicine Hospital of Gaotang County

Liaocheng, Shandong, China

Site Status

Community Health Center of Duqiao

Weinan, Shanxi, China

Site Status

Chinese Medicine Hospital of Sanyuan County

Xianyang, Shanxi, China

Site Status

People's Hospital of Fuyuan County

Qujing, Yunnan, China

Site Status

Chinese Medicine Hospital of Luliang County

Qujing, Yunnan, China

Site Status

People's Hospital of Luliang County

Qujing, Yunnan, China

Site Status

Chinse Medical Hospital of Shizong County

Qujing, Yunnan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Yao Q, Wei T, Qiu H, Cai Y, Yuan L, Liu X, Li X. Epigenetic Effects of Natural Products in Inflammatory Diseases: Recent Findings. Phytother Res. 2025 Jan;39(1):90-137. doi: 10.1002/ptr.8364. Epub 2024 Nov 8.

Reference Type DERIVED
PMID: 39513382 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Qingkailing-V5.0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Homeopathic Drug Proving Trial
NCT01061229 COMPLETED PHASE1